Skip to main content
. 2023 Nov 21;14:1269605. doi: 10.3389/fphar.2023.1269605

TABLE 7.

Ultrasound imaging to estimate fatty infiltration of the liver in participants in the two groups, berberine (B) and control (C), at enrolment and after 90 days of treatment.

Liver ultrasound B–baseline C–baseline B–90 days C–90 days
Number of subjects, n 26 35 25 32
Normal, n (%) 21 (80.8%) 21 (60.0%) 23 (92.0%) 25 (78.1%)
NAFLD, n (%) 5 (19.2%) 14 (40.0%) 2 (8.0%) 2 (8.0%)
p between “baseline” values: 0.0832 between “90 days” values: 0.1413

NAFLD, Non-Alcoholic Fatty Liver Disease.